Gout

Relationship between Chronic Kidney Disease and Gout Uncovered for the First Time

By analyzing information from the National Health and Nu­trition Examination Survey (NHANES) from 1988-1994 and 2007-2010, researchers have uncovered a 30% rate of gout prevalence among Americans with severe chronic kidney disease (CKD). They also found significantly higher rates of gout among individuals with lower average estimated glomerular filtration rates (eGFRs) or higher levels of albuminuria, even after adjusting for uric acid levels (Juraschek SP, et al. Semin Arthritis Rheum. 2013 Jan 8 [Epub ahead of print]).

By Rosemary Frei, MSc

Prophylaxis with Colchicine Often Used Inappropriately in Patients with Gout

Colchicine is an effective prophylaxis against gout only when it is taken consistently over 14 days by patients who are prone to gout attacks, according to study results by researchers from Boston University.

By Wayne Kuznar

Patients with Gout Considered Controlled with Urate-Lowering Therapy Often Continue to Flare

By Phoebe Starr

Acute flares leading to hospitalizations and emergency department visits pose a significant health burden, yet approximately 75% of patients with gout who are considered “controlled” on urate-lowering therapy continued to have flares over a 1-year period, according to a study presented at the 2012 meeting of the American College of Rheumatology.

Gout Treatments Continue to Target Inflammation, Pain, with Many New Drugs in the Pipeline

By Wayne Kuznar

The self-reported misery of many patients with gout is driving health professionals to stay at the forefront of administering effective treatments and expedient diagnoses to reduce pain and inflammation, one expert reported at the 2012 meeting of the American College of Rheumatology.